These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33350738)

  • 1. Efficacy and safety of intravenous thrombolysis with alteplase for treating acute ischemic stroke at different time windows: A protocol for systematic review and meta-analysis.
    Huang B; Qian F; Fan X; Guan S; Zheng Y; Yang J; Xu F
    Medicine (Baltimore); 2020 Dec; 99(52):e23620. PubMed ID: 33350738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese herbal injections combined with rt-PA intravenous thrombolysis for acute ischemic stroke: A systematic review and meta-analysis protocol.
    Wu J; Wang L; Dong X; Li Z; Wang K; Li L; Liu J
    Medicine (Baltimore); 2021 Mar; 100(10):e25004. PubMed ID: 33725879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolysis with 0.9 mg/kg alteplase for acute ischaemic stroke: a network meta-analysis of treatment delay.
    Chen X; Shen Y; Huang C; Geng Y; Yu Y
    Postgrad Med J; 2020 Nov; 96(1141):680-685. PubMed ID: 31857497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of different doses of tenecteplase in the treatment of acute ischemic stroke: A protocol for systematic review and meta-analysis.
    Chen G; Bai C; Zhu Z; Li J; Shao S
    Medicine (Baltimore); 2021 Jan; 100(3):e23805. PubMed ID: 33545944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke Thrombolysis in Patients Taking Ticagrelor -Two Successful Cases and a Review of the Literature.
    Landzberg DR; English S; Frankel M; Navalkele D
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105520. PubMed ID: 33310594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Intravenous Tenecteplase Versus Alteplase in Treating Acute Ischemic Stroke With Diabetes and Admission Hyperglycemia.
    Liu H; Jin A; Pan Y; Meng X; Li H; Li Z; Wang Y; Li S
    J Am Heart Assoc; 2024 Oct; 13(20):e036393. PubMed ID: 39392168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis on Low- and Standard-Dose Regimes of Alteplase Thrombolytic Therapy for Acute Ischemic Stroke: Efficacy and Safety.
    Zhao G; Huang T; Zheng M; Cui Y; Liu Y; Cheng Z; Wang Z
    Eur Neurol; 2018; 79(1-2):68-73. PubMed ID: 29241193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials.
    Xiong Y; Wang L; Li G; Yang KX; Hao M; Li S; Pan Y; Wang Y
    Stroke Vasc Neurol; 2024 Aug; 9(4):360-366. PubMed ID: 37640500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
    Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
    Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thrombolysis in a mobile stroke unit versus in hospital for patients with ischemic stroke: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Chen J; Lin X; Huang R; Luo M; Cai Y; Zou W
    Medicine (Baltimore); 2021 Jan; 100(1):e23676. PubMed ID: 33429734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
    Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.
    Stroke Thrombolysis Trialists' Collaborative Group
    Int J Stroke; 2013 Jun; 8(4):278-83. PubMed ID: 23639145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and a model for prognosis prediction after intravenous thrombolysis with alteplase in acute ischemic stroke based on propensity score matching.
    Huang P; Yi X
    Int J Immunopathol Pharmacol; 2024; 38():3946320241274231. PubMed ID: 39167070
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study.
    Luo Z; Zhou Y; He Y; Yan S; Chen Z; Zhang X; Chen Y; Tong LS; Zhong W; Hu H; Zhang K; Yang J; Campbell BCV; Lou M
    Stroke Vasc Neurol; 2024 Jun; 9(3):318-323. PubMed ID: 37527920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
    Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
    Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
    Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.